IDEXX Laboratories, Inc. NASDAQ:IDXX

IDEXX Laboratories stock price today

$636.75
+221.82
+53.46%
Financial Health
0
1
2
3
4
5
6
7
8
9

IDEXX Laboratories stock price monthly change

-15.79%
month

IDEXX Laboratories stock price quarterly change

-15.79%
quarter

IDEXX Laboratories stock price yearly change

-25.52%
year

IDEXX Laboratories key metrics

Market Cap
33.61B
Enterprise value
40.74B
P/E
60.22
EV/Sales
12.09
EV/EBITDA
40.26
Price/Sales
11.87
Price/Book
65.68
PEG ratio
-8.48
EPS
10.43
Revenue
3.72B
EBITDA
1.15B
Income
866.56M
Revenue Q/Q
7.09%
Revenue Y/Y
8.56%
Profit margin
20.17%
Oper. margin
26.69%
Gross margin
59.52%
EBIT margin
26.69%
EBITDA margin
30.87%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

IDEXX Laboratories stock price history

IDEXX Laboratories stock forecast

IDEXX Laboratories financial statements

IDEXX Laboratories, Inc. (NASDAQ:IDXX): Profit margin
Jun 2023 943.63M 224.23M 23.76%
Sep 2023 915.52M 212.23M 23.18%
Dec 2023 901.60M 194.52M 21.58%
Mar 2024 964.09M 235.57M 24.44%
IDEXX Laboratories, Inc. (NASDAQ:IDXX): Analyst Estimates
Sep 2025 1.10B 269.04M 24.4%
Oct 2025 1.08B 266.78M 24.6%
Dec 2025 1.06B 250.82M 23.51%
Mar 2026 1.17B 302.15M 25.7%
  • Analysts Price target

  • Financials & Ratios estimates

IDEXX Laboratories, Inc. (NASDAQ:IDXX): Debt to assets
Jun 2023 2870806000 1.77B 61.9%
Sep 2023 3086404000 1.78B 57.96%
Dec 2023 3259925000 1.77B 54.46%
Mar 2024 3353515000 1.78B 53.22%
IDEXX Laboratories, Inc. (NASDAQ:IDXX): Cash Flow
Jun 2023 200.31M -27.47M -151.03M
Sep 2023 272.43M -27.83M -43.03M
Dec 2023 249.85M -30.43M -101.84M
Mar 2024 198.58M -106.94M -144.07M

IDEXX Laboratories alternative data

IDEXX

IDEXX Laboratories, Inc. (NASDAQ:IDXX): Google Trends - IDEXX
12 Feb 2023 81
19 Feb 2023 85
26 Feb 2023 84
5 Mar 2023 78
12 Mar 2023 78
19 Mar 2023 79
26 Mar 2023 87
2 Apr 2023 85
9 Apr 2023 83
16 Apr 2023 82
23 Apr 2023 79
30 Apr 2023 74
7 May 2023 71
14 May 2023 89
21 May 2023 87
28 May 2023 72
4 Jun 2023 79
11 Jun 2023 77
18 Jun 2023 74
25 Jun 2023 52

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

IDEXX Laboratories, Inc. (NASDAQ:IDXX): Job openings
Sep 2023 208
Oct 2023 184
Nov 2023 195
Dec 2023 198
Jan 2024 186
Feb 2024 178
Apr 2024 240
May 2024 262
Jun 2024 202
Jul 2024 215
IDEXX Laboratories, Inc. (NASDAQ:IDXX): Employee count
Sep 2023 11,000
Oct 2023 11,000
Nov 2023 11,000
Dec 2023 11,000
Jan 2024 11,000
Feb 2024 11,000
Mar 2024 11,000
Apr 2024 11,000
May 2024 11,000
Jun 2024 11,000
Jul 2024 11,000

IDEXX Laboratories other data

82.92% +0.17%
of IDXX is owned by hedge funds
71.78M +195.78K
shares is hold by hedge funds

IDEXX Laboratories, Inc. (NASDAQ:IDXX): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 18764
Feb 2024 0 43524
Mar 2024 0 9508
May 2024 0 200
Sep 2024 0 500
Nov 2024 0 344
Transaction Date Insider Security Shares Price per share Total value Source
Sale
VANDEBROEK SOPHIE V. director
Common Stock 344 $420.44 $144,630
Sale
SZOSTAK M ANNE director
Common Stock 500 $469.37 $234,686
Option
SCHRECK MICHAEL officer: Executive Vice President
Common Stock 164 N/A N/A
Option
SCHRECK MICHAEL officer: Executive Vice President
Restricted Stock Unit 164 N/A N/A
Option
SMITH MARTIN ALEXANDER officer: Executive Vice President
Common Stock 18 N/A N/A
Option
SMITH MARTIN ALEXANDER officer: Executive Vice President
Restricted Stock Unit 18 N/A N/A
Option
MCKEON BRIAN P officer: EVP, CFO.. Common Stock 192 N/A N/A
Option
MCKEON BRIAN P officer: EVP, CFO.. Restricted Stock Unit 192 N/A N/A
Option
MAZELSKY JONATHAN JAY director, officer.. Common Stock 384 N/A N/A
Option
MAZELSKY JONATHAN JAY director, officer.. Restricted Stock Unit 384 N/A N/A
Patent
Application
Filling date: 28 Feb 2022 Issue date: 8 Sep 2022
Grant
Filling date: 16 Sep 2019 Issue date: 6 Sep 2022
Application
Filling date: 17 Feb 2022 Issue date: 1 Sep 2022
Grant
Filling date: 19 Oct 2018 Issue date: 23 Aug 2022
Application
Filling date: 28 Mar 2022 Issue date: 14 Jul 2022
Application
Filling date: 17 Dec 2021 Issue date: 23 Jun 2022
Grant
Filling date: 8 Apr 2019 Issue date: 14 Jun 2022
Application
Filling date: 10 Feb 2022 Issue date: 2 Jun 2022
Application
Filling date: 9 Jun 2021 Issue date: 5 May 2022
Application
Filling date: 30 Sep 2021 Issue date: 31 Mar 2022
Thursday, 26 December 2024
zacks.com
Thursday, 19 December 2024
globenewswire.com
Friday, 13 December 2024
fool.com
Wednesday, 11 December 2024
zacks.com
Monday, 9 December 2024
businesswire.com
Friday, 22 November 2024
zacks.com
Thursday, 21 November 2024
businesswire.com
Sunday, 10 November 2024
seekingalpha.com
Wednesday, 6 November 2024
fool.com
Tuesday, 5 November 2024
fool.com
Thursday, 31 October 2024
seekingalpha.com
businesswire.com
benzinga.com
zacks.com
zacks.com
zacks.com
reuters.com
businesswire.com
Monday, 28 October 2024
zacks.com
Thursday, 24 October 2024
zacks.com
Wednesday, 16 October 2024
zacks.com
Monday, 30 September 2024
businesswire.com
Thursday, 5 September 2024
zacks.com
Wednesday, 21 August 2024
businesswire.com
Sunday, 11 August 2024
seekingalpha.com
Tuesday, 6 August 2024
benzinga.com
seekingalpha.com
zacks.com
zacks.com
zacks.com
  • What's the price of IDEXX Laboratories stock today?

    One share of IDEXX Laboratories stock can currently be purchased for approximately $636.75.

  • When is IDEXX Laboratories's next earnings date?

    Unfortunately, IDEXX Laboratories's (IDXX) next earnings date is currently unknown.

  • Does IDEXX Laboratories pay dividends?

    No, IDEXX Laboratories does not pay dividends.

  • How much money does IDEXX Laboratories make?

    IDEXX Laboratories has a market capitalization of 33.61B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.72% to 3.66B US dollars.

  • What is IDEXX Laboratories's stock symbol?

    IDEXX Laboratories, Inc. is traded on the NASDAQ under the ticker symbol "IDXX".

  • What is IDEXX Laboratories's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of IDEXX Laboratories?

    Shares of IDEXX Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are IDEXX Laboratories's key executives?

    IDEXX Laboratories's management team includes the following people:

    • Mr. Jonathan J. Mazelsky Pres, Chief Executive Officer & Director(age: 64, pay: $2,540,000)
    • Mr. Brian P. McKeon Chief Financial Officer, Executive Vice President & Treasurer(age: 63, pay: $1,350,000)
    • Mr. James F. Polewaczyk Executive Vice President & Chief Commercial Officer(age: 61, pay: $1,110,000)
    • Mr. Michael J. Lane Executive Vice President and GM of Reference Laboratories & Information Technology(age: 57, pay: $1,110,000)
    • Ms. Sharon E. Underberg Senior Vice President, Gen. Counsel & Corporation Sec.(age: 64, pay: $881,050)
    • Mr. Jonathan W. Ayers Senior Advisor & Director(age: 69, pay: $169,870)
  • How many employees does IDEXX Laboratories have?

    As Jul 2024, IDEXX Laboratories employs 11,000 workers.

  • When IDEXX Laboratories went public?

    IDEXX Laboratories, Inc. is publicly traded company for more then 34 years since IPO on 21 Jun 1991.

  • What is IDEXX Laboratories's official website?

    The official website for IDEXX Laboratories is idexx.com.

  • Where are IDEXX Laboratories's headquarters?

    IDEXX Laboratories is headquartered at One IDEXX Drive, Westbrook, ME.

  • How can i contact IDEXX Laboratories?

    IDEXX Laboratories's mailing address is One IDEXX Drive, Westbrook, ME and company can be reached via phone at +20 75560300.

IDEXX Laboratories company profile:

IDEXX Laboratories, Inc.

idexx.com
Exchange:

NASDAQ

Full time employees:

11,000

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

One IDEXX Drive
Westbrook, ME 04092

CIK: 0000874716
ISIN: US45168D1046
CUSIP: 45168D104